Analysis Finds Slant in Articles on a Diabetes Drug, Avandia
Monday, April 12, 2010 - 12:00
in Health & Medicine
A new analysis has found that experts who were paid by Avandia’s manufacturer have been significantly more likely than others to draw positive conclusions about the drug’s safety and efficacy.